Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,854 papers from all fields of science
Search
Sign In
Create Free Account
Myleran
Known as:
Myléran
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (1)
Busulfan
Busulfan 2 MG Oral Tablet [Myleran]
Myelosan
Mylecytan
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans.
M. Jarman
,
R. Milsted
,
J. Smyth
,
R. Kinas
,
K. Pankiewicz
,
W. Stec
Cancer Research
1979
Corpus ID: 11382895
The comparative metabolism of the enantiomers of cyclo phosphamide and of the racemate has been studied in humans. Four patients…
Expand
1975
1975
Increased urinary excretion of nucleic acid and nicotinamide derivatives by rats after treatment with alkylating agents.
B. Chu
,
P. D. Lawley
Chemico-Biological Interactions
1975
Corpus ID: 41823927
1972
1972
Observation of dividing spermatocytes for chromosome aberrations induced in mouse spermatogonia by chemical mutagens.
A. Léonard
,
G. Linden
Mutation research
1972
Corpus ID: 11880279
Highly Cited
1969
Highly Cited
1969
The letal action of monofunctional and bifunctional alkylating agents on T7 coliphage.
W. Verly
,
L. Brakier
Biochimica et Biophysica Acta
1969
Corpus ID: 32602662
1969
1969
The sensitivity of a yoshida sarcoma to methylene dimethane sulphonate
B. Fox
International Journal of Cancer
1969
Corpus ID: 9668541
The action of methylene dimethane sulphonate on the growth rate of the Yoshida sarcoma in rats is described. 1) The tumour, even…
Expand
1968
1968
Experimental Thrombocytopenia Induced by Busulphan (Myleran) in Rabbits: Extremely Low Platelet Levels and Intact Plasma Clotting System
S. Evensen
,
M. Jeremić
,
P. Hjort
Thrombosis and Haemostasis
1968
Corpus ID: 20101957
Summary The effects of 2 intraperitoneal injections of the alkylating agent Busulphan (each of 25 mg/kg body weight, 3 days…
Expand
Highly Cited
1961
Highly Cited
1961
A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy.
R. Kyle
,
R. Schwartz
,
H. Oliner
,
W. Dameshek
Blood
1961
Corpus ID: 32089388
Four patients who developed a clinical syndrome characterized by hyperpigmentation of the skin, weakness, fatigue, weight loss…
Expand
Highly Cited
1960
Highly Cited
1960
Transplacental transmission of busulfan (myleran) in a mother with leukemia. Production of fetal malformation and cytomegaly.
I. Diamond
,
M. Anderson
,
Samuel R. McCreadie
Pediatrics
1960
Corpus ID: 6735231
A female infant, born of a mother with leukemia who received 6-mercaptopurine and x-ray therapy early in the pregnancy and…
Expand
Highly Cited
1956
Highly Cited
1956
Treatment of chronic granulocytic leukemia with myleran.
J. Louis
,
L. Limarzi
,
W. Best
A M A Archives of Internal Medicine
1956
Corpus ID: 29940439
In the hope of finding a less toxic analogue of nitrogen mustard, Haddow replaced the methyl groups in the nitrogen mustard…
Expand
1955
1955
Cataracts produced in rats by 1, 4-dimethanesulfonoxybutane (myleran).
C. Solomon
,
A. Light
,
E. J. de Beer
A M A Archives of Ophthalmology
1955
Corpus ID: 39485762
Haddow and Timmis,1in the course of preparation of a series of sulfonic acid compounds, found only the sulfonic acid esters…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required